Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.93 |
| ▸ | FDPS | P14324 | 15/20 | 0.47 |
| ▸ | PGK1 | P00558 | 1/20 | 0.45 |
| ▸ | PGK2 | P07205 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etidronic Acid SCHEMBL1924063 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL719163 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL10532992 | 0.96 | LMNA (1.00) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL18607 | 0.96 | LMNA (1.00) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL10706705 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL3896726 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL17580248 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL6141145 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL10524952 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL205727 | 0.93 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3691450-B1 | QUATERNARY AMMONIUM ETIDRONATES | INNOVATIVE WATER CARE LLC (US) | 2024-08-21 | — | — | EP | claimed |
| US-10793586-B2 | Quaternary ammonium etidronates | INNOVATIVE WATER CARE, LLC (US) | 2020-10-06 | — | — | US | claimed |
| US-20190106445-A1 | QUATERNARY AMMONIUM ETIDRONATES | THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT | 2019-04-11 | — | — | US | claimed |
| CN-107236961-A | A kind of metallic article cleaning agent of corrosion-resistant inoxidizability | 合肥汇之新机械科技有限公司 | 2017-10-10 | — | — | CN | claimed |
| CN-106967988-A | A kind of surface cleaning agent of metallic article | 合肥汇之新机械科技有限公司 | 2017-07-21 | — | — | CN | claimed |
| CN-106947608-A | A kind of heat exchanger quick deoiling cleaning agent and its application method | 安徽普瑞普勒传热技术有限公司 | 2017-07-14 | — | — | CN | claimed |
| WO-2026104463-A1 | IMPROVED EPOXIDATION CATALYST | BASF SE (DE) | 2026-05-21 | — | — | WO | disclosed |
| US-20250049669-A1 | COMPOSITION COMPRISING A SPECIFIC OXIDATION DYE PRECURSOR AND TWO SPECIFIC ACIDS | L'OREAL (FR) | 2025-02-13 | — | — | US | disclosed |
| US-20250025398-A1 | COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR AND TWO PARTICULAR ACIDS | L'OREAL (FR) | 2025-01-23 | — | — | US | disclosed |
| EP-4422587-A1 | COMPOSITION COMPRISING A SPECIFIC OXIDATION DYE PRECURSOR AND TWO SPECIFIC ACIDS | L'OREAL (FR) | 2024-09-04 | — | — | EP | disclosed |
| EP-4422590-A1 | COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR AND TWO PARTICULAR ACIDS | L'OREAL (FR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240279194-A1 | SHUTDOWN METHOD FOR A PROCESS FOR PREPARING AN OLEFIN OXIDE | DOW GLOBAL TECHNOLOGIES LLC | 2024-08-22 | — | — | US | disclosed |
| EP-3691450-B1 | QUATERNARY AMMONIUM ETIDRONATES | INNOVATIVE WATER CARE LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| WO-2019071070-A1 | QUATERNARY AMMONIUM ETIDRONATES | ARCH CHEMICALS, INC. (US) | 2019-04-11 | — | — | WO | disclosed |
| US-20190106445-A1 | QUATERNARY AMMONIUM ETIDRONATES | THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT | 2019-04-11 | — | — | US | disclosed |
| CN-107236961-A | A kind of metallic article cleaning agent of corrosion-resistant inoxidizability | 合肥汇之新机械科技有限公司 | 2017-10-10 | — | — | CN | disclosed |
| CN-106967988-A | A kind of surface cleaning agent of metallic article | 合肥汇之新机械科技有限公司 | 2017-07-21 | — | — | CN | disclosed |
| CN-106947608-A | A kind of heat exchanger quick deoiling cleaning agent and its application method | 安徽普瑞普勒传热技术有限公司 | 2017-07-14 | — | — | CN | disclosed |
| WO-2010061240-A1 | METHOD FOR FORMULATING A REDUCED PHOSPHORUS BRANDED CLEANING PRODUCT OR CLEANING SYSTEM | ECOLAB INC. (US) | 2010-06-03 | — | — | WO | disclosed |
| US-20090099054-A1 | METHOD FOR FORMULATING A REDUCED PHOSPHORUS BRANDED CLEANING PRODUCT OR CLEANING SYSTEM | ECOLAB INC. (US) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049669-A1 | COMPOSITION COMPRISING A SPECIFIC OXIDATION DYE PRECURSOR AND TWO SPECIFIC ACIDS | MT-ND6, KRT18, PYCR1 | LMNA 1303/4885FDPS 2889/4885PGK1 2475/4885 |
| US-10793586-B2 | Quaternary ammonium etidronates | POLR1C, QARS1, ATP6V1E1 | LMNA 4707/4885FDPS 3178/4885PGK1 887/4885 |
| US-20250025398-A1 | COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR AND TWO PARTICULAR ACIDS | MT-ND6, CYP2D6, CYP26B1 | LMNA 1415/4885FDPS 2850/4885PGK1 2876/4885 |
| US-20190106445-A1 | QUATERNARY AMMONIUM ETIDRONATES | POLR1C, QARS1, ATP6V1E1 | LMNA 4707/4885FDPS 3178/4885PGK1 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.